Context Therapeutics Inc (CNTX) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Context Therapeutics Inc

NASDAQ | CNTX

0.72

USD

+0.038 (+5.58%)

AT CLOSE (AS OF Apr 3, 2025)

$61M

MARKET CAP

P/E Ratio

-0.46

EPS

$2.8

52 Week High

$0.55

52 Week Low

LIFE SCIENCES

Sector

CNTX Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

CNTX Technicals

Tags:

CNTX Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	-$6.1M
Total Revenue	$1.2M
Cost Of Revenue	$7.3M
Costof Goods And Services Sold	-
Operating Income	-$25M
Selling General And Administrative	$7.3M
Research And Development	$18M
Operating Expenses	$25M
Investment Income Net	-
Net Interest Income	$1.2M
Interest Income	-
Interest Expense	-
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	-
Income Before Tax	-$24M
Income Tax Expense	$0
Interest And Debt Expense	-
Net Income From Continuing Operations	-$25M
Comprehensive Income Net Of Tax	-$25M
Ebit	-$25M
Ebitda	-
Net Income	-$24M

Revenue & Profitability

Earnings Performance

CNTX Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2023)

Field	Value (USD)
Total Assets	$16M
Total Current Assets	$16M
Cash And Cash Equivalents At Carrying Value	$14M
Cash And Short Term Investments	$14M
Inventory	-
Current Net Receivables	-
Total Non Current Assets	$16K
Property Plant Equipment	$16K
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	-
Intangible Assets Excluding Goodwill	-
Goodwill	-
Investments	-
Long Term Investments	-
Short Term Investments	-
Other Current Assets	-
Other Non Current Assets	$0
Total Liabilities	$4.2M
Total Current Liabilities	$4.2M
Current Accounts Payable	$2.4M
Deferred Revenue	-
Current Debt	-
Short Term Debt	-
Total Non Current Liabilities	-
Capital Lease Obligations	-
Long Term Debt	-
Current Long Term Debt	-
Long Term Debt Noncurrent	-
Short Long Term Debt Total	-
Other Current Liabilities	-
Other Non Current Liabilities	-
Total Shareholder Equity	$12M
Treasury Stock	-
Retained Earnings	-
Common Stock	$16K
Common Stock Shares Outstanding	$16M

yearly Cash Flow (As of Dec 31, 2023)

Field	Value (USD)
Operating Cashflow	-$21M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	$984K
Change In Operating Assets	-$792K
Depreciation Depletion And Amortization	$12K
Capital Expenditures	$0
Change In Receivables	-
Change In Inventory	-
Profit Loss	-$25M
Cashflow From Investment	$0
Cashflow From Financing	$0
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$24M

yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	-$6.1M
Total Revenue	$1.2M
Cost Of Revenue	$7.3M
Costof Goods And Services Sold	-
Operating Income	-$25M
Selling General And Administrative	$7.3M
Research And Development	$18M
Operating Expenses	$25M
Investment Income Net	-
Net Interest Income	$1.2M
Interest Income	-
Interest Expense	-
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	-
Income Before Tax	-$24M
Income Tax Expense	$0
Interest And Debt Expense	-
Net Income From Continuing Operations	-$25M
Comprehensive Income Net Of Tax	-$25M
Ebit	-$25M
Ebitda	-
Net Income	-$24M

CNTX Profile

Context Therapeutics Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of chronic pain. The company is headquartered in Boston, Massachusetts.

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	9.42%	-	742,693,504
NVDA	$101.80	-7.81%	$2.68T	334,149,797
INTC	$22.43	2.05%	$95.85B	240,924,655
F	$9.55	-5.96%	$39.53B	213,326,329
LCID	$2.32	-3.33%	$7.67B	211,931,403

Symbol	Price	Change %	Market Cap	Volume
JNJ	$159.81	2.86%	$399.65B	13,235,689
PG	$172.57	1.81%	$399.61B	6,993,394
ABBV	$201.56	-1.77%	$364.89B	7,584,184
NVO	$67.12	-1.65%	$308.32B	8,797,694
AZN	$73.92	2.35%	$225.70B	7,926,952

Symbol	Price	Change %	Market Cap	Volume
VCIG	$5.99	1,796.17%	$26.40M	310,904
MKTW	$9.23	1,692.58%	$19.91M	126,841
MRM	$0.69	87.76%	$2.91M	53,662,982
PTIX	$0.42	84.14%	$4.04M	177,332,811
OSRH	$2.47	68.03%	$40.06M	89,471,971

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	21,865,554
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
OMQS	$0.04	-66.36%	$1.50M	950,669

Quick Links

CNTX $0.72 (+5.58%) Quote details